These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 26725100)

  • 1. The cost-effectiveness of surgical resection and cesium-131 intraoperative brachytherapy versus surgical resection and stereotactic radiosurgery in the treatment of metastatic brain tumors.
    Wernicke AG; Yondorf MZ; Parashar B; Nori D; Clifford Chao KS; Boockvar JA; Pannullo S; Stieg P; Schwartz TH
    J Neurooncol; 2016 Mar; 127(1):145-53. PubMed ID: 26725100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of stereotactic radiosurgery with and without whole-brain radiotherapy for the treatment of newly diagnosed brain metastases.
    Hall MD; McGee JL; McGee MC; Hall KA; Neils DM; Klopfenstein JD; Elwood PW
    J Neurosurg; 2014 Dec; 121 Suppl():84-90. PubMed ID: 25434941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of stereotactic radiosurgery versus whole-brain radiation therapy for up to 10 brain metastases.
    Lester-Coll NH; Dosoretz AP; Magnuson WJ; Laurans MS; Chiang VL; Yu JB
    J Neurosurg; 2016 Dec; 125(Suppl 1):18-25. PubMed ID: 27903191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A matched-pair analysis of clinical outcomes after intracavitary cesium-131 brachytherapy versus stereotactic radiosurgery for resected brain metastases.
    Julie DA; Lazow SP; Vanderbilt DB; Taube S; Yondorf MZ; Sabbas A; Pannullo S; Schwartz TH; Wernicke AG
    J Neurosurg; 2021 May; 134(5):1447-1454. PubMed ID: 32413856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing the cost-effectiveness of two brain metastasis treatment modalities from a payer's perspective: stereotactic radiosurgery versus surgical resection.
    Vuong DA; Rades D; van Eck AT; Horstmann GA; Busse R
    Clin Neurol Neurosurg; 2013 Mar; 115(3):276-84. PubMed ID: 22705458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cost-effectiveness of stereotactic radiosurgery versus surgical resection in the treatment of brain metastasis in Vietnam from the perspective of patients and families.
    Vuong DA; Rades D; Le AN; Busse R
    World Neurosurg; 2012 Feb; 77(2):321-8. PubMed ID: 22120377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness analysis of a randomized study comparing radiosurgery with radiosurgery and whole brain radiation therapy in patients with 1 to 3 brain metastases.
    Lal LS; Byfield SD; Chang EL; Franzini L; Miller LA; Arbuckle R; Reasonda L; Feng C; Adamus A; Swint JM
    Am J Clin Oncol; 2012 Feb; 35(1):45-50. PubMed ID: 21293245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness Analysis of Stereotactic Radiosurgery Alone Versus Stereotactic Radiosurgery with Upfront Whole Brain Radiation Therapy for Brain Metastases.
    Kim H; Rajagopalan MS; Beriwal S; Smith KJ
    Clin Oncol (R Coll Radiol); 2017 Oct; 29(10):e157-e164. PubMed ID: 28552517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical Technique and Clinically Relevant Resection Cavity Dynamics Following Implantation of Cesium-131 (Cs-131) Brachytherapy in Patients With Brain Metastases.
    Wernicke AG; Lazow SP; Taube S; Yondorf MZ; Kovanlikaya I; Nori D; Christos P; Boockvar JA; Pannullo S; Stieg PE; Schwartz TH
    Oper Neurosurg (Hagerstown); 2016 Mar; 12(1):49-60. PubMed ID: 27774500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I/II study of resection and intraoperative cesium-131 radioisotope brachytherapy in patients with newly diagnosed brain metastases.
    Wernicke AG; Yondorf MZ; Peng L; Trichter S; Nedialkova L; Sabbas A; Kulidzhanov F; Parashar B; Nori D; Clifford Chao KS; Christos P; Kovanlikaya I; Pannullo S; Boockvar JA; Stieg PE; Schwartz TH
    J Neurosurg; 2014 Aug; 121(2):338-48. PubMed ID: 24785322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
    Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
    J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cesium-131 brachytherapy for recurrent brain metastases: durable salvage treatment for previously irradiated metastatic disease.
    Wernicke AG; Smith AW; Taube S; Yondorf MZ; Parashar B; Trichter S; Nedialkova L; Sabbas A; Christos P; Ramakrishna R; Pannullo SC; Stieg PE; Schwartz TH
    J Neurosurg; 2017 Apr; 126(4):1212-1219. PubMed ID: 27257835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cost effectiveness of stereotactic radiosurgery versus surgical resection in the treatment of solitary metastatic brain tumors.
    Rutigliano MJ; Lunsford LD; Kondziolka D; Strauss MJ; Khanna V; Green M
    Neurosurgery; 1995 Sep; 37(3):445-53; discussion 453-5. PubMed ID: 7501109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness analysis of neurocognitive-sparing treatments for brain metastases.
    Savitz ST; Chen RC; Sher DJ
    Cancer; 2015 Dec; 121(23):4231-9. PubMed ID: 26372146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cost-effectiveness and cost-utility analysis of radiosurgery vs. resection for single-brain metastases.
    Mehta M; Noyes W; Craig B; Lamond J; Auchter R; French M; Johnson M; Levin A; Badie B; Robbins I; Kinsella T
    Int J Radiat Oncol Biol Phys; 1997 Sep; 39(2):445-54. PubMed ID: 9308949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-Effectiveness of Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy: a Critical Review.
    Lester-Coll NH; Sher DJ
    Curr Oncol Rep; 2017 Jun; 19(6):41. PubMed ID: 28421482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereotactic radiosurgery for patients with multiple brain metastases: a case-matched study comparing treatment results for patients with 2-9 versus 10 or more tumors.
    Yamamoto M; Kawabe T; Sato Y; Higuchi Y; Nariai T; Watanabe S; Kasuya H
    J Neurosurg; 2014 Dec; 121 Suppl():16-25. PubMed ID: 25434933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of stereotactic radiation vs. wedge resection vs. wedge resection plus Cesium-131 brachytherapy in early stage lung cancer.
    Parashar B; Port J; Arora S; Christos P; Trichter S; Nori D; Wernicke AG
    Brachytherapy; 2015; 14(5):648-54. PubMed ID: 25998071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Outcomes of Large Brain Metastases Treated With Neurosurgical Resection and Intraoperative Cesium-131 Brachytherapy: Results of a Prospective Trial.
    Wernicke AG; Hirschfeld CB; Smith AW; Taube S; Yondorf MZ; Parashar B; Nedialkova L; Kulidzhanov F; Trichter S; Sabbas A; Ramakrishna R; Pannullo S; Schwartz TH
    Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1059-1068. PubMed ID: 28721889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcomes of gastrointestinal brain metastases treated with radiotherapy.
    Sanghvi SM; Lischalk JW; Cai L; Collins S; Nair M; Collins B; Unger K
    Radiat Oncol; 2017 Feb; 12(1):43. PubMed ID: 28245881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.